OMG-Net: A Deep Learning Framework Deploying Segment Anything to Detect Pan-Cancer Mitotic Figures from Haematoxylin and Eosin-Stained Slides
Shen, Zhuoyan, Simard, Mikael, Brand, Douglas, Andrei, Vanghelita, Al-Khader, Ali, Oumlil, Fatine, Trevers, Katherine, Butters, Thomas, Haefliger, Simon, Kara, Eleanna, Amary, Fernanda, Tirabosco, Roberto, Cool, Paul, Royle, Gary, Hawkins, Maria A., Flanagan, Adrienne M., Fekete, Charles-Antoine Collins
–arXiv.org Artificial Intelligence
Mitotic activity is an important feature for grading several cancer types. Counting mitotic figures (MFs) is a time-consuming, laborious task prone to inter-observer variation. Inaccurate recognition of MFs can lead to incorrect grading and hence potential suboptimal treatment. In this study, we propose an artificial intelligence (AI)-aided approach to detect MFs in digitised haematoxylin and eosin-stained whole slide images (WSIs). Advances in this area are hampered by the limited number and types of cancer datasets of MFs. Here we establish the largest pan-cancer dataset of mitotic figures by combining an in-house dataset of soft tissue tumours (STMF) with five open-source mitotic datasets comprising multiple human cancers and canine specimens (ICPR, TUPAC, CCMCT, CMC and MIDOG++). This new dataset identifies 74,620 MFs and 105,538 mitotic-like figures. We then employed a two-stage framework (the Optimised Mitoses Generator Network (OMG-Net) to classify MFs. The framework first deploys the Segment Anything Model (SAM) to automate the contouring of MFs and surrounding objects. An adapted ResNet18 is subsequently trained to classify MFs. OMG-Net reaches an F1-score of 0.84 on pan-cancer MF detection (breast carcinoma, neuroendocrine tumour and melanoma), largely outperforming the previous state-of-the-art MIDOG++ benchmark model on its hold-out testing set (e.g. +16% F1-score on breast cancer detection, p<0.001) thereby providing superior accuracy in detecting MFs on various types of tumours obtained with different scanners.
arXiv.org Artificial Intelligence
Jul-17-2024
- Country:
- Asia > Middle East
- Israel (0.04)
- Europe
- Ireland (0.04)
- Switzerland > Basel-City
- Basel (0.04)
- United Kingdom
- England
- Greater London > London (0.04)
- Staffordshire (0.04)
- Wales (0.04)
- England
- North America > United States
- New Jersey (0.04)
- Asia > Middle East
- Genre:
- Research Report
- Experimental Study (1.00)
- New Finding (1.00)
- Research Report
- Industry:
- Health & Medicine > Therapeutic Area > Oncology
- Breast Cancer (0.57)
- Sarcoma (0.69)
- Health & Medicine > Therapeutic Area > Oncology
- Technology: